AIDSVAX® Research Collaborations |
No. |
Collaborating Institution |
Investigator(s) |
Type of Collaboration |
1 |
Armed Forces Research Institute for Medical Sciences (AFRIMS)* |
o'Connell, Karasawa, Excler, et.al. |
vaccine, rgp 120 reagents, serological specimens |
2 |
CHUV (Centre Hospitalier Universitaire Vadois)* |
Pantaleo |
clinical study, vaccine |
3 |
Dartmouth College |
Ackerman |
serological specimens |
4 |
Duke University, Department of Medicine, Human Vaccine Institute |
Haynes, Montefiori, Tomares, Moody, et.al. |
rgp 120 reagents, serological specimens, clinical study |
5 |
EuroVacc Foundation* |
Pantaleo |
clinical studies, vaccine |
6 |
Fred C. Hutchinson Cancer Research Center* |
Gilbert, McElrath, Frahm |
clinical study data,rgp 120 reagents |
7 |
GeoVax (private sector company) |
Robinson |
clinical study |
8 |
Harvard University/Beth Israel Deaconess Medical Center* |
Barouch, Shanta |
vaccine |
9 |
HIV Vaccine Trials Network (HVTN)* |
Various |
clinical studies |
10 |
International AIDS Vaccine Initiative (IAVI) |
Priddy |
clinical study |
11 |
Immunetics (private sector company)* |
Levine |
serological specimens |
12 |
iPox Foundation* |
Pantaleo |
clinical studies |
13 |
Joan & Sanford I. Weil Medical College of Cornell University |
Moore |
rgp 120 reagents, serological specimens |
14 |
Los Alamos National Lab |
Korber |
serological specimens |
15 |
Massachusetts General Hospital (Ragon Institute)* |
Alter |
serological specimens |
16 |
Massachusetts Institute of Technology |
Lowe |
serological specimens |
17 |
National Institutes of Health (NIH) / National Institute of Allergy and Infectious Diseases (NIAID) / Division of AIDS (DAIDS)* |
Various |
clinical studies, serological specimens |
18 |
NIH / NIAID -Vaccine Research Center* |
Koup, Bailer, Anthos Wyatt, Mascola |
rgp 120 reagents, serological specimens |
19 |
NIH - Biostatistics Research Branch of the Division of Clinical Research |
Follmann |
clinical study data |
20 |
New York University Langone School of Medicine* |
Zolla-Pazner, Marmor, Cardozo |
serological specimens, clinical study data |
21 |
New York University/Veteran's Administration New York Harbor Healthcare System* |
Hioe |
rgp 120 reagents, serological specimens |
22 |
PaxVax (private sector company) |
Gurwith, Connors |
clinical study |
23 |
Rockefeller University/Howard Hughes Medical Institute |
Neuaezweig |
vaccine |
24 |
Rush University Medical Center |
Baum |
rgp 120 reagents |
25 |
San Francisco Department of Public Health |
Buchbinder |
clinical study data |
26 |
Sanofi Pasteur (private sector company)* |
Tartaglia, Phogat, et.al. |
clinical studies |
27 |
SRI International |
Wang |
serological samples |
28 |
Tulane University |
Weazy |
vaccine |
29 |
University of Alabama, Birmingham* |
Shaw, Hahn, Bar |
serological specimens |
30 |
University of California, Irvine* |
Forthal |
rgp 120 reagents |
31 |
University of California, San Francisco* |
Wittington |
clinical study data |
32 |
University of California, Santa Cruz* |
Berman |
rgp 120 reagents, serological specimens |
33 |
University of Kansas |
Desaire |
rgp 120 reagents |
34 |
University of Maryland, Baltimore |
DeVico |
vaccine, serological specimens |
35 |
University of Melbourne |
Kent |
rgp 120 reagents |
36 |
University of Nebraska, Lincoln* |
Li |
vaccine, rgp 120 reagents |
37 |
University of North Carolina, Charlotte |
Sun |
clinical study data |
38 |
University of Pennsylvania* |
Shaw, Hahn, Bar |
serological specimens |
39 |
University of Washington |
Greenberg, Goodreau |
vaccine, clinical study data |
40 |
US Food & Drug Administration |
Krause |
vaccine |
41 |
US Military HIV Research Program (MHRP) and Walter Reed Army Institute of Research (WRAIR)* |
Michael, Kim, Robb, et.al. |
clinical studies, vaccine, rgp 120 reagents, serological specimens |
42 |
Vanderbilt University |
Crowe |
serological specimens |
43 |
University of Rochester |
Johnson |
Clinical study data |
44 |
University of JAEN (Spain) |
Caruz |
Clinical study data |
45 |
University of Rochester |
Johnson |
Clinical study data |
46 |
Ohio State University |
Ganesan |
serological specimens |
47 |
Imperial College, London |
Weber |
Clinical study, vaccine, rgp 120 reagents |
48 |
Mt. Sinai Health System |
Hioe |
rgp reagents |
49 |
University of Georgia |
Song |
VAX004 database subset |
* With these institutions, GSID has entered into multiple cooperative research and development, clinical trial and material transfer agreements.
|